期刊文献+

单核细胞骨调素的表达水平与狼疮肾炎 被引量:1

Expression level of osteopotin and lupus nephritis
下载PDF
导出
摘要 目的:研究骨调素(OPN)在狼疮性肾损害中的作用。方法:采用酶联免疫吸附试验(ELISA)检测了90例系统性红斑狼疮(SLE)患者、15例非SLE肾损害患者及30例对照血浆OPN的水平,应用半定量RT-PCR方法,测定以上各组外周血单个核细胞(PBMCs)OPN的表达。结果:狼疮处于疾病活动时PBMCs OPNmRNA表达上调,尤其是狼疮肾炎活动组患者PBMCs OPNmRNA表达增加最为显著(P<0.01),PBMCs OPNmRNA表达不仅与总狼疮疾病活动指数评分呈正相关(r=0.532,P<0.001),而且与狼疮疾病活动指数肾评分呈正相关(r=0.584,P<0.001),而非狼疮肾脏疾病组仅低水平表达,与正常对照组水平相近似(P>0.05)。狼疮活动组血清OPN水平较非活动组及正常对照组均明显升高(P<0.01),但活动性狼疮肾炎组与无肾损伤组之间血清OPN水平的差异无显著性(P>0.05)。结论:狼疮处于疾病活动时PBMCs OPNmRNA表达上调,并与狼疮肾炎的疾病活动情况密切相关。 Objective: To explore the role of osteopotin in lupus nephritis (LN). Methods: Sere osteopotin( OPN )levels were measured by enzyme linked immunosorbent assay in 90 patients with systemic lupus erythematosus (SLE), 15 non-SLE patients with renal impairment, and 30 healthy volunteers. OPN mRNA expression in peripheral blood mononuclear cells (PBMCs) was also investigated with reverse transcription-polymerase chain reaction semi-quantitative method.Results: The expression of OPN was significantly higher in active LN groups than in all other groups( P 〈0.01 ) ,and there was a close correlation between OPN expression and the overall SLE disease activity index score ( r = 0.584, P 〈 0.001) and the SLE disease activity index renal score( r = 0.584, P 〈 0.001) .Low expression of OPN was observed in disease controls and healthy controls. The sera levels of OPN were significantly higher in patients with active disease than in patients with inactive SLE and controls,but no significant difference was found between the active LN groups and non-renal involvement group ( P 〉 0.05). Conclusion:The expression of PBMCs OPN mRNA is up regulation in active SLE. Meanwhile,its expression levels are correlated with the activity of LN.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第3期271-273,共3页 Chinese Journal of Immunology
关键词 红斑狼疮 系统性 骨调素 狼疮性肾炎 Lupus erythematosus, systemic Osteopontin Lupus nephritis
  • 相关文献

参考文献9

  • 1Tsokos G C. Systemic lupus erythematosus. A disease with a complex pathogenesis [ J ], lancet, 2001 ; 358 Suppl: S65-S68.
  • 2Gerard C, Rollins B J. Chemokines and diseases [ J ]. Nature Immunol, 2001 ; 2(2) : 108-115.
  • 3Yu X Q, Wu L L, Huang X R et al. Osteopontin expression in progressive renal injury in remnant kidney:role of angiotensin(Ⅱ )[J]. Kindey Int, 2000; 58 : 1469-1480.
  • 4叶任高.系统性红斑狼疮[M].见:叶任高主编.内科学.第5版.北京:人民卫生出版社,2000:909.
  • 5Bombandier C, Gladmann D D, Urowitz M B et al. The committee on prognosis studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients[J]. Arthritis Rheum, 1992;35 (6) :630-540.
  • 6Kim H M, Lee D S, Yang S H et al. The polymorphrism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE[J]. J Kid Dis,2002;40(6) : 1146-1152.
  • 7Panzer U, Thaiss F, Iahner G et al. Monocyte chemoattraetant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis[ J]. Kidney Int, 2001 ;59:1762-1769.
  • 8李龙,陈运芬,陈艳,陈永雄,余学清,尹培达,罗建华.狼疮性肾炎肾组织中骨调素的研究[J].贵阳医学院学报,2002,27(3):196-199. 被引量:2
  • 9Wong C K, Lit L C, Tam L S et al. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus[ J]. Rheumatology,2005;44 (5) :602-606.

二级参考文献2

共引文献3

同被引文献16

  • 1Meacock R. Dale N. Harrison MJ. The humanistic and economic burden of systemic lupus erythematosus: a systematic review[J]. Pharmacoeconornics , 2013. 31 ( 1): 49-61.
  • 2Bollain- Y -Goytia 11. Gonz61ez-Castaileda M. Torres-Del-Muro F. et al. Increased excretion of urinary podocytes in lupus nephritis[J]. India 1 Nephrol , 2011, 21(3): 166-171.
  • 3Kpop K. Eikmans M. Baelde HJ. et al. Expression of podocyteassociated molecules in acquired human kidney diseases[J], J Am Soc Nephrol , 2003. 14(8): 2063-2071.
  • 4Desai N. Cimbaluk D. Lewis El , et al. Proteinuria in membranous lupus nephritis: the pathology is in the podocyte[J], Lupus. 2013. 22(5): 461-468.
  • 5Brahler S. Ising C. Hagmann H. et al. Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria[J]. Am 1 Physiol Renal Physiol , 2012. 303 (10): FI473-1485.
  • 6Gladman DD. Ibanez D. Urowitz MB. et al. Systemic lupus ertyhematosus disease activity index 2000[J]. J Rheumatol , 2002.29(2): 288-291.
  • 7Kraft SW. Schwartz MM. Korbet SM. et al. Glomerular podocytopathy in patients with systemic lupus erythematosus[J].J Am Soc Nephrol. 2005. 16(1): 175-179.
  • 8Yap DY. Lai KN. Pathogenesis of renal disease in systemic lupus erythematosus-the role of autoantibodies and lymphocytes subset abnormalitieslj]. Int 1 Mol Sci. 2015. 16(4): 7917-7931.
  • 9Sun CY. Shen Y. Chen XW. et al. The characteristics and significance of locally infiltrating B cells in lupus nephritis and their association with local BAFF expreseiorr[J]. IntJ Rheumatol. 2013. 2013: 954292.
  • 10Okamoto A. Fujio K. Tsuno NH. et al. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice[J], Kidney Int , 2012. 82(9): 969-979.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部